These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2993774)

  • 1. Stimulation of ACTH release by naloxone: central or peripheral action?
    Jezová D
    Life Sci; 1985 Sep; 37(11):1007-13. PubMed ID: 2993774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.
    Hashimoto K; Suemaru S; Hattori T; Takao T; Inoue H; Sugawara M; Kageyama J; Ota Z
    Endocrinol Jpn; 1986 Dec; 33(6):813-20. PubMed ID: 3034557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone does not antagonize PCP-induced stimulation of the pituitary-adrenal axis in the rat.
    Pechnick RN; George R; Poland RE
    Life Sci; 1989; 44(2):143-7. PubMed ID: 2536875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated rats.
    Jezová D; Vigas M; Jurcovicová J
    Life Sci; 1982 Jul; 31(4):307-14. PubMed ID: 6292645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of naltrexone on plasma corticosterone in opiate-naive rats: a central action.
    Eisenberg RM
    Life Sci; 1984 Mar; 34(12):1185-91. PubMed ID: 6538628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of naloxone on basal and stress-induced ACTH and corticosterone secretion in the male rat--site and mechanism of action.
    Siegel RA; Chowers I; Conforti N; Feldman S; Weidenfeld J
    Brain Res; 1982 Oct; 249(1):103-9. PubMed ID: 6291703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats.
    Manzanares J; Corchero J; Fuentes JA
    Brain Res; 1999 Aug; 839(1):173-9. PubMed ID: 10482810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of oxytocin and naloxone on the plasma levels of corticosterone in the rat].
    Montilla P; Muñoz JL; Ríos JE; Muñoz MC
    Rev Esp Fisiol; 1989 Dec; 45(4):319-22. PubMed ID: 2631154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of plasma corticosterone induced by loperamide in rats.
    Giagnoni G; Parolaro D; Sala M; Marabini L; Senini R; Gori E
    Eur J Pharmacol; 1982 Apr; 79(1-2):101-4. PubMed ID: 6282595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in plasma ACTH after dopaminergic stimulation in rats.
    Jezová D; Jurcovicová J; Vigas M; Murgas K; Labrie F
    Psychopharmacology (Berl); 1985; 85(2):201-3. PubMed ID: 2989967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain beta-endorphin and other opioids are involved in restraint stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat.
    Yamauchi N; Shibasaki T; Wakabayashi I; Demura H
    Brain Res; 1997 Nov; 777(1-2):140-6. PubMed ID: 9449422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among the behavioral, noradrenergic, and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin.
    Wieczorek M; Dunn AJ
    Brain Behav Immun; 2006 Sep; 20(5):477-87. PubMed ID: 16330180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC; Cooper TA
    Neuroendocrinology; 1986; 42(5):421-6. PubMed ID: 3010154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone inhibits and morphine potentiates the adrenal steroidogenic response to ACTH.
    Heybach JP; Vernikos J
    Eur J Pharmacol; 1981 Oct; 75(1):1-6. PubMed ID: 6274654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the loci of action of phencyclidine on the CNS-pituitary-adrenal axis.
    Pechnick RN; Chun BM; George R; Hanada K; Poland RE
    J Pharmacol Exp Ther; 1990 Jul; 254(1):344-9. PubMed ID: 2164101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation.
    Rossier J; French E; Rivier C; Shibasaki T; Guillemin R; Bloom FE
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):666-9. PubMed ID: 6244573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS.
    Lenczowski MJ; Van Dam AM; Poole S; Larrick JW; Tilders FJ
    Am J Physiol; 1997 Dec; 273(6):R1870-7. PubMed ID: 9435639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.